InMed Pharmaceuticals Inc. (INM) — 分析师展望 / 分析师共识目标价为. 基于 2 位分析师评级, 共识为 看涨 — 2 买入.
分析师预估 每股收益(EPS)为 $-321.40 和 营收为 $0.01B (下一财年).
每股收益(EPS)历史表现: 2024: 实际 $-1.01 vs 预期 $-321.40 (超预期 +99.7%). 2025: 实际 $-11.44 vs 预期 $-100.00 (超预期 +88.6%). 分析师准确度: 0%.
INM 分析师评级
Buy
基于过去3个月内 2 位分析师对 InMed Pharmaceuticals Inc. 的评级
EPS 预测 — INM
0%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024
Actual –$1.01
vs Est –$321.40
▲ 31,813.4% off
2025
Actual –$11.44
vs Est –$100.00
▲ 774.1% off
Profitability Outlook
Company has been making losses in all recent fiscal years. Analysts expect losses to continue near-term.
营收预测 — INM
73%
Analyst Accuracy
Fair
2 years compared
Actual vs Estimate
2024
Actual $0.005B
vs Est $0.005B
▼ 17.8% off
2025
Actual $0.005B
vs Est $0.007B
▼ 37.0% off
Revenue Trend
Revenue has been relatively flat. Analysts expect stable revenue going forward.
